FDA Investigator Hyojong Kwon, PhD

Hyojong Kwon, PhD has conducted inspections on 10 sites in 6 countries as of 02 Aug 2010. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
10
Last Inspection Date:
02 Aug 2010
Investigator Role:
FDA Investigator
Redica ID:
100000049
Countries of Inspections:
Japan, India, United States of America, Netherlands, United Kingdom of Great Britain and Northern Ireland, Germany
FDA Investigators that have inspected at least one site in common with Hyojong Kwon, PhD:
Alan P Kurtzberg, Allen F Hall, Amanda E Lewin, PhD, Atul J Agrawal, Barbara A Rusin, Barbara M Frazier, Brandy D Brown, Byungja E Marciante, Charles R Bonapace, PhD, Charles R Cote, RIC, Chase Bourke, PhD, Corey K Reno, Courtney N Long, Daniel L Aisen, Dawn L Wydner, Denise L Burosh, Denise M Visco, Investigator, Dina A Tallman, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Geoffrey K Kilili, Gregory W Smith, Gulshan R Anand, James R Fleckenstein, Jasjeet K Sekhon, Jason D Abel, John A Kadavil, PhD, Jonee J Mearns, Jyoti B Patel, PhD, Kara A Scheibner, PhD, Kip J Hanks, Kirtida Patel, Li Hongpaul Yeh, PhD, Linda R Kuchenthal, Lori A Gioia, Makini Cobourne Duval, PhD, Marcelo O Mangalindan, Jr, Martin K Yau, PhD, Matthew J Gretkierewicz, Michael Serrano, Rebecca T Davis, Ronald R Ruff, Ruben C Ayala, PharmD, Sam Chan, Sandra A Hughes, Scott B Laufenberg, Stephen D Brown, Wr Bowman, Xiaohan Cai, PhD, Yvins Dezan

Hyojong Kwon, PhD's Documents

Publish Date Document Type Title
January, 2010 FDA 483 Pharmaceutical Research Associates Group B.V. - Form 483, 2010-01-22
January, 2010 EIR Pharmaceutical Research Associates Group B.V. - EIR, 2010-01-22
February, 2008 FDA 483 Tandem Labs A LabCorp Company - Form 483, 2008-02-14
September, 2008 FDA 483 Labcorp Early Development Laboratories, Inc. - Form 483, 2008-09-25

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more